Related Experiment Video
Updated: Jun 20, 2026
08:40
Chronic Salmonella Infection Induced Intestinal Fibrosis
Published on: September 22, 2019
[Chronic inflammatory intestinal diseases. Pathophysiology and therapy].
K Herrlinger1, B Wittig, E F Stange
1Zentrum für Innere Medizin I, Robert Bosch Krankenhaus, Stuttgart.
Der Internist
|September 25, 2009
Summary
Chronic inflammatory intestinal diseases involve a disrupted gut barrier, yet current therapies target the adaptive immune system, causing side effects. Future research aims for causal therapies addressing the gut barrier
Area of Science:
- Gastroenterology and Immunology
- Focuses on the complex interplay between the intestinal barrier, microbial environment, and immune responses in chronic inflammatory intestinal diseases.
Context:
- Chronic inflammatory intestinal diseases (e.g., Crohn's disease, ulcerative colitis) exhibit a significant gap between understanding their pathogenesis and current therapeutic strategies.
- Pathogenesis is increasingly linked to intestinal barrier dysfunction and host-microbe interactions, supported by evidence from genetics, microbiology, morphology, and innate immunology.
- Current evidence-based therapies primarily target effectors of the adaptive immune system, often involving aggressive biological treatments with potential adverse effects.
Purpose:
- To address the dichotomy between the established knowledge of intestinal disease pathogenesis and the limitations of current therapeutic approaches.
- To explore potential future developments that could lead to more causal and effective therapies for chronic inflammatory intestinal diseases.
- To bridge the inconsistencies in understanding and treating these complex conditions.
Summary:
- Evidence strongly implicates a disrupted intestinal barrier and luminal bacteria in the pathogenesis of chronic inflammatory intestinal diseases.
- Despite this understanding, therapies predominantly focus on modulating the adaptive immune system, leading to aggressive treatments and side effects.
- This discrepancy highlights a need for innovative therapeutic strategies that target the root causes of intestinal inflammation.
Impact:
- Highlights the medical and scientific need for a more cohesive understanding and treatment paradigm for chronic inflammatory intestinal diseases.
- Suggests a shift towards therapies that address the intestinal barrier and microbial dysbiosis, potentially leading to safer and more effective treatments.
- Provides a foundation for future research and development of causal therapies for conditions like ulcerative colitis and Crohn's disease.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
01:30Inflammatory Bowel Disease II: Crohn's Disease
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...